🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Want to learn more about prostate cancer ? And how we can use PSMA RLT ? Come to todays symposium with the outstanding clinicians Derya Tilki, MD Prof Joe O'Sullivan and Prof Maria de Santis European Association of Nuclear Medicine (EANM) #eanm2023

Fantastic multidisciplinary session on PSMA theranostics Derya Tilki, MD Ken Herrmann Maria De Santis European Association of Nuclear Medicine (EANM) #eanm2023

Delineating staging pelvic lymph node dissection before radiotherapy and positioning primary prostatectomy. Presentation by Derya Tilki, MD Martini-Klinik am UKE. #ESMO23 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3s583CM ESMO - Eur. Oncology

Happening now… Vip Patel using the Edge Medical robot on a patient in Harbin, China. But he is 1200km away in Beijing! Zero latency. Looks like a Da Vinci S HD #telesurgery #roboticsurgery GU Cast | Urology podcast!

Just finished developing the first draft of questions for 2024. As tombal put it: THE unique moment of intense cogitation on where we stand on advanced prostate cancer. If you want to be a part of it register now for Advanced Prostate Cancer Consensus Conference at apccc.org

Meet some of the esteemed chairs of #APCCC24, driving forward the conversation in advanced #prostatecancer. Connect with the forefront of oncology leadership. Visit now: apccc.org/apccc-2024/sci… #OncologyLeaders aurelius omlin silke gillessen Derya Tilki, MD Neha Vapiwala neal shore

You want to learn about prostate cancer ? No better place to go: APCCC 2024 in Lugano! Register here ! apccc.org Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin Axel S. Merseburger Derya Tilki, MD prof. Stefano Fanti Michael Hofman

🔬 The upcoming APCCC 2024 session 2 delves into the critical topic of Treatment for Biochemical Recurrence/PSA Persistence in prostate cancer. Expect in-depth discussions with Derya Tilki, MD Thomas Zilli prof. Barbara Jereczek-Fossa tombal Daniel E Spratt Jason Efstathiou Paul Nguyen

#GU24 #ASCOEdBook chapter: Emerging possibilities to de-escalate treatment in #ProstateCancer: brnw.ch/21wGrF1 Kosj Yamoah MD, PhD Derya Tilki, MD #pcsm #gucsm

Setting the stage: Biochemical recurrence after local treatment for #ProstateCancer. Presentation by Derya Tilki, MD Martini-Klinik am UKE. #GU24 written coverage by Zach Klaassen Georgia Cancer Center on UroToday > bit.ly/3vRCZrQ ASCO

Thanks Derya Tilki, MD UroToday.com for great summary on BCR 🙏🏻 Thanks ++ for highlighting our ANZUP #DIPPER trial, coord The George Institute for Global Health Open in multiple sites around Australia incl @MetroNorthHHS #stvincentssydney Peter Mac Radiation Oncology ProsTIC #GenesisCareAU (+soon Int’l sites)

🔍 Session 2 of #APCCC24 delves into Treatment for Biochemical Recurrence/PSA Persistence, featuring leading experts in the field. Chaired by Thomas Zilli and Derya Tilki, MD in Part 1 and Jason Efstathiou and prof. Barbara Jereczek-Fossa in Part 2, the session includes additional insightful

🌟 Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24! Join global experts in consensus discussions that shape future treatments. 🗓️ Register now for an unmissable experience: apccc.org #Oncology #GU24 #oncoalert

Prostate cancer cases are expected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, new analysis suggests. More from the Lancet Commission on #ProstateCancer in-thread 🧵 ▶️ hubs.li/Q02r1b720

Hot debate on role of ePLND for #prostatecancer in context of -ve PSMA-PET at #EAU24 plenary Declan Murphy vs Pr. Alexandre de La Taille - European Association of Urology (EAU) guidelines updated: stronger recommendation for use of PSMA-PET to stage & weaker for ePLND

🗓️As the hybrid #APCCC24 swiftly approaches with its start date of April 25th, we're eager to revisit Session 2, focusing on the critical areas of Biochemical Recurrence and PSA Persistence in prostate cancer. Derya Tilki and Thomas Zilli skillfully guide this session in Part

The latest version of the prostate cancer guidelines are now summarised and available. You have heard the rumours now read what we changed and why! European Urology European Association of Urology (EAU) Derya Tilki, MD authors.elsevier.com/c/1iwC714kplyy…

The summary paper (part II) of the EAU PCa guidelines is now available online. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Philip Cornford European Urology European Association of Urology (EAU) authors.elsevier.com/c/1i-uV14kplyy…

I'm thrilled to be able to share this report from the symposium CAncer or Not Cancer?: Evaluating and Reconsidering GG1 prostate cancer (CANCER-GG1?), out today JNCI When is prostate cancer really cancer? academic.oup.com/jnci/article/d…